Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome.

By S. Coughlin, L. Mawdsley, J. Mugarza, P. Calverley, John P H Wilding. European Heart Journal, 2004

875 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Experimental and Cognitive Psychology, Physiology

View Paper: https://www.semanticscholar.org/paper/e0b659cee346c0d09bbef739090be865aee6c2b7

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Michael J. Pencina
2. Virend K. Somers
3. S. Daniels
4. I. Neeland

In Experimental and Cognitive Psychology

1. J. Floras
2. T. Young

In Physiology

1. Virend K. Somers
2. J. Floras
3. I. Neeland
4. T. Young
5. Atul Malhotra
6. Naresh M. Punjabi

Citations in the corpus

• Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Coun (2008, background): “In addition to concern about these as “confounding” factors in investigating the independent role of OSA in promotion of cardiovascular disease, there also is interest in the concurrent presence of the constellation of OSA, cardiovascular disease, and their common risk factors (10,51,58).”
• Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association (2023, background): “…as a consequence of CKM syndrome, with associated clinical challenges including kidney failure, 6 premature cognitive decline, 7,8 metabolic dysfunction–associated steatotic liver disease (previously nonalcoholic fatty liver disease), 9,10 obstructive sleep apnea, 11 and increased risk for cancer.”